Cargando…

The status of licensed pharmacy workforce in Saudi Arabia: a 2030 economic vision perspective

BACKGROUND: The economy of Saudi Arabia is currently undergoing a major transformation which will have an impact on employment in the pharmacy sector. However, quantitative data characterizing the pharmacy workforce in the Kingdom are currently not available. Therefore, the aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	AlRuthia, Yazed, Alsenaidy, Mohammad A., Alrabiah, Haitham K., AlMuhaisen, Abdullah, Alshehri, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022294/ https://www.ncbi.nlm.nih.gov/pubmed/29954408 http://dx.doi.org/10.1186/s12960-018-0294-8

Ejemplares similares

Shortage of psychotropic medications in community pharmacies in Saudi Arabia: Causes and solutions
por: Al-Ruthia, Yazed Sulaiman, et al.
Publicado: (2017)

The characteristics and distribution of dentist workforce in Saudi Arabia: A descriptive cross-sectional study
por: AlBaker, Abdulaziz A., et al.
Publicado: (2017)

Pharmacy students’ attitudes toward patient safety in Saudi Arabia: a cross-sectional study
por: Alwhaibi, Monira, et al.
Publicado: (2020)

Community Pharmacists’ Views of the Enforced Antibiotics Dispensing Law and Its Impact on Oral Antibiotics Sales in Saudi Arabia
por: AlRukban, Mohammed, et al.
Publicado: (2020)

Advancing pharmaceuticals and patient safety in Saudi Arabia: A 2030 vision initiative
por: Alhawassi, Tariq M., et al.
Publicado: (2018)

The cost-effectiveness of sequential versus standard triple therapy for Helicobacter pylori eradication in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2021)

Assessing the pharmacy students’ knowledge of common medical terms after a curricular change in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2020)

2020 Update to Spinal Muscular Atrophy Management in Saudi Arabia
por: Bashiri, Fahad A., et al.
Publicado: (2021)

The Commonly Utilized Natural Products during the COVID-19 Pandemic in Saudi Arabia: A Cross-Sectional Online Survey
por: AlNajrany, Sina M., et al.
Publicado: (2021)

Associations of Depression and Anxiety with Stigma in a Sample of Patients in Saudi Arabia Who Recovered from COVID-19
por: Alkathiri, Munirah A, et al.
Publicado: (2022)

Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2019)

How can Saudi Arabia reform its public hospital payment models? A narrative review
por: AlRuthia, Yazed, et al.
Publicado: (2020)

Saudi Arabia and aerospace medicine in the era of the national vision of 2030
por: Shirah, Bader H., et al.
Publicado: (2020)

Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia (Short Title: COVID-19 Survival and Cost in Saudi Arabia)
por: Khan, Anas A., et al.
Publicado: (2020)

Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study
por: AlMutairi, Lama T, et al.
Publicado: (2022)

Estimation Of Direct Medical Costs Of Middle East Respiratory Syndrome Coronavirus Infection: A Single-Center Retrospective Chart Review Study
por: AlRuthia, Yazed, et al.
Publicado: (2019)

The characteristics and distribution of emergency medical services in Saudi Arabia
por: Al-Wathinani, Ahmed M., et al.
Publicado: (2023)

Pharmacy education in Saudi Arabia: A vision of the future
por: Aljadhey, Hisham, et al.
Publicado: (2017)

Impact of vision 2030 on traffic safety in Saudi Arabia
por: Dahim, Mohammed A.H.
Publicado: (2018)

An analysis of pharmacy workforce capacity in Saudi Arabia
por: Almaghaslah, Dalia
Publicado: (2023)

Adopting global tools for the advancement of pharmacy practice and workforce in Saudi Arabia
por: Almaghaslah, Dalia, et al.
Publicado: (2022)

The need for national medical licensing examination in Saudi Arabia
por: Bajammal, Sohail, et al.
Publicado: (2008)

Estimated Direct Medical Cost of Osteoporosis in Saudi Arabia: A Single-Center Retrospective Cost Analysis
por: Balkhi, Bander, et al.
Publicado: (2021)

Local causes of essential medicines shortages from the perspective of supply chain professionals in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2023)

Cost effectiveness of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients in Saudi Arabia: A Single–Center retrospective cohort study
por: AlRuthia, Yazed, et al.
Publicado: (2023)

Quality Infrastructure of Saudi Arabia and Its Importance for Vision 2030
por: Kumar, Vinay, et al.
Publicado: (2022)

The Impact of COVID-19 on Essential Medicines and Personal Protective Equipment Availability and Prices in Saudi Arabia
por: Aljadeed, Rana, et al.
Publicado: (2021)

Clinical and economic evaluations of natalizumab, rituximab, and ocrelizumab for the management of relapsing-remitting multiple sclerosis in Saudi Arabia
por: Alharbi, Mansour A., et al.
Publicado: (2023)

Patients’ Behavior Regarding Dietary or Herbal Supplements before and during COVID-19 in Saudi Arabia
por: Aldwihi, Leen A., et al.
Publicado: (2021)

The use of active learning strategies in healthcare colleges in the Middle East
por: AlRuthia, Yazed, et al.
Publicado: (2019)

Building a Hepatitis C Virus Treatment Strategy to Achieve the 2030 Vision for Saudi Arabia
por: Al-Judaibi, Bandar
Publicado: (2017)

Erratum: Khan, A.A., et al. Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia (Short Title: COVID-19 Survival and Cost in Saudi Arabia). Int. J. Environ. Res. Public Health 2020, 17, 7458
por: Khan, Anas A., et al.
Publicado: (2020)

Cost-effectiveness of telemedicine care for patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia
por: Faleh AlMutairi, Manal, et al.
Publicado: (2021)

Drug-drug interactions and pharmacists’ interventions among psychiatric patients in outpatient clinics of a teaching hospital in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2019)

Demographics, comorbidities, and outcomes among young and middle-aged COVID-19 patients in Saudi Arabia
por: Alali, Amer S., et al.
Publicado: (2021)

Predictors of Hospitalization Among Older Adults with COVID-19 in Saudi Arabia: A Cross-Sectional Study of a Nationally Representative Sample
por: Alamri, Fahad, et al.
Publicado: (2021)

Real-World Impact of Switching From Insulin Glargine (Lantus(®)) to Basaglar(®) and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2022)

Healthcare Transformation in Saudi Arabia: An Overview Since the Launch of Vision 2030
por: Alasiri, Ahmed Ali, et al.
Publicado: (2022)

Proxy-Reported Quality of Life and Access to Nusinersen Among Patients with Spinal Muscular Atrophy in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2021)

Exploring the value of a Doctor of Philosophy program in Pharmaceutical Outcomes and Policy Research in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_45mcua4cas0ta0l822nojfscp5